Literature DB >> 12775419

Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes.

D Galey1, K Becker, N Haughey, A Kalehua, D Taub, J Woodward, M P Mattson, A Nath.   

Abstract

Astrocytes may be infected with the human immunodeficiency virus type 1 (HIV-1) or exposed to the HIV protein gp120, yet their role in the pathogenesis of HIV dementia is largely unknown. To characterize the effects of HIV on astrocytic transcription, microarray analysis and ribonuclease protection assays (RPA) were performed. Infection of astrocytes by HIV or treatment with gp120 had differential and profound effects on gene transcription. Of the 1153 oligonucleotides on the immune-based array, the expression of 108 genes (53 up; 55 down) and 82 genes (32 up; 50 down) were significantly modulated by gp120 and HIV infection respectively. Of the 1153 oligonucleotides on the neuro-based array, 58 genes (25 up; 33 down) and 47 genes (17 up; 30 down) were significantly modulated by gp120 and HIV infection respectively. Chemokine and cytokine induction occurred predominantly by HIV infection, whereas gp120 had no significant effect. These results were confirmed by RPA. The authors conclude that profound alterations of astrocytic function occur in response to HIV infection or interaction with viral proteins, suggesting that astrocytes may play an important role in the pathogenesis of HIV dementia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775419     DOI: 10.1080/13550280390201119

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  32 in total

1.  Selective transport of SC1 mRNA, encoding a putative extracellular matrix glycoprotein, during postnatal development of the rat cerebellum and retina.

Authors:  A J Mothe; I R Brown
Journal:  Brain Res Mol Brain Res       Date:  2000-03-10

2.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication.

Authors:  Claudia Cicala; James Arthos; Sara M Selig; Glynn Dennis; Douglas A Hosack; Donald Van Ryk; Marion L Spangler; Tavis D Steenbeke; Prateeti Khazanie; Neil Gupta; Jun Yang; Marybeth Daucher; Richard A Lempicki; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.

Authors:  G K Geiss; R E Bumgarner; M C An; M B Agy; A B van 't Wout; E Hammersmark; V S Carter; D Upchurch; J I Mullins; M G Katze
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

Review 4.  Pathobiology of human immunodeficiency virus dementia.

Authors:  A Nath
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

5.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.

Authors:  A Nath; N J Haughey; M Jones; C Anderson; J E Bell; J D Geiger
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

6.  HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation.

Authors:  I W Park; C K Ullrich; E Schoenberger; R K Ganju; J E Groopman
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

7.  Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.

Authors:  L A Ryan; J Zheng; M Brester; D Bohac; F Hahn; J Anderson; W Ratanasuwan; H E Gendelman; S Swindells
Journal:  J Infect Dis       Date:  2001-08-15       Impact factor: 5.226

8.  Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.

Authors:  V F Vidal; N Castéran; C J Riendeau; H Kornfeld; E C Darcissac; A Capron; G M Bahr
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

9.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation.

Authors:  M Castedo; K F Ferri; J Blanco; T Roumier; N Larochette; J Barretina; A Amendola; R Nardacci; D Métivier; J A Este; M Piacentini; G Kroemer
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  31 in total

1.  Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets.

Authors:  Paul J McLaren; Michael Mayne; Stuart Rosser; Teri Moffatt; Kevin G Becker; Francis A Plummer; Keith R Fowke
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 2.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

3.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 4.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

5.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 6.  Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.

Authors:  Shuxian Hu; Wen S Sheng; Robert Bryan Rock
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-18       Impact factor: 4.147

7.  Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1.

Authors:  Rebeca Geffin; Ricardo Martinez; Roberto Perez; Biju Issac; Micheline McCarthy
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-07       Impact factor: 4.147

8.  Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.

Authors:  Nisha Dogra; Corinna Warburton; W Robert McMaster
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

10.  Possible involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in MoMuLV-ts1-induced apoptosis in astrocytes.

Authors:  Na Liu; Xianghong Kuang; Hun-Taek Kim; George Stoica; Wenan Qiang; Virginia Lee Scofield; Paul K Y Wong
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.